• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail

Return to search Page to restart search Return to Orphan Designation Search Page Return to Search Page
Generic Name:  recombinant human monoclonal antibody against activin receptors type II
Trade Name:  n/a
Date Designated:  06/18/2012
Orphan Designation:  Treatment of inclusion body myositis
Orphan Designation Status:  Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Novartis Pharmaceuticals Corp.
One Health Plaza
East Hanover, New Jersey 07936

The sponsor address listed is the last reported by the sponsor to OOPD.